Orbis Diagnostics

How Orbis Diagnostics is making a difference in the world

Established in 2016, Orbis brings together a proven team of world-leading researchers, backed by New Zealand’s largest early stage deep-tech investor, Pacific Channel. Orbis has developed a ‘lab on a disk’ testing platform that uses its microfluidic platform technology to miniaturise and automate accurate lab testing for use at points of need. Originally designed for the cowshed, the first product to run on this platform was able to accurately quantify progesterone in milk for heat detection, to inform the timing of artificial insemination. With the outbreak of COVID-19, Orbis recognised how the unique features of the system could help re-enable safe travel amidst a pandemic and quickly repurposed the technology to deliver a quantitative immunity test for COVID-19.

Formed in 2016, Orbis has raised seed capital from Pacific Channel and the University of Auckland Inventors' Fund.

Learn more by visiting orbisdiagnostics.com